Literature DB >> 16269269

Janus kinase-2 signaling mediates apoptosis in rat cardiomyocytes.

Eduardo Mascareno1, Daniel L Beckles, M A Q Siddiqui.   

Abstract

We tested the hypothesis that activation Jak2, which is prominently involved in the up-regulation of the renin-angiotensin system (RAS), constitutes a focal point in relaying signals triggered by a Angiotensin II (Ang II) and hypoxia/reoxygenation separately to cause an enhanced susceptibility of cardiac myocyte to apoptotic cell death. Ang II-treated adult cardiomyocytes in culture exhibited an increased level of apoptosis that accompanied activation of pro-apoptotic as well as anti-apoptotic signaling pathways. We observed increased phosphorylation of Jak2 kinase, Stat1, JNK, with increased expression of Bax protein, followed by an increase in caspase-1 and caspase-3 activity. Activation of these pro-apoptotic pathways was blocked by the Jak2 pharmacological inhibitor, Tyrphostin AG490. We also observed an increase in phosphorylation of cardioprotective pathway components, namely S6 ribosomal protein, and heat shock protein 27 (HSP27). Likewise, the oxidative stress, via the hypoxia/reoxygenation treatment of rat adult cardiomyocytes, produced apoptosis that was dependent upon activation of Jak2. The apoptotic response was not only reduced by Losartan, an inverse agonist of the AT1, receptor, but by treatment with AG490 as well. Taken together, these observations provide clear evidence in favor of Jak2 signaling as mediator of the apoptotic response in cardiomyocytes. However, there was a concomitant induction of cytoprotective signaling that presumably provides a negative feed-back to the deleterious effects of the agonist.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269269     DOI: 10.1016/j.vph.2005.08.023

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  5 in total

1.  Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion.

Authors:  Maria Cecilia S Freitas; Yoichiro Uchida; Danyun Zhao; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2010-05       Impact factor: 5.799

2.  Myocardial Hypertrophic Remodeling and Impaired Left Ventricular Function in Mice with a Cardiac-Specific Deletion of Janus Kinase 2.

Authors:  Xiaohong T Gan; Venkatesh Rajapurohitam; Jenny Xue; Cathy Huang; Suresh Bairwa; Xilan Tang; Jeffrey T-Y Chow; Melissa F W Liu; Felix Chiu; Kazuhito Sakamoto; Kay-Uwe Wagner; Morris Karmazyn
Journal:  Am J Pathol       Date:  2015-12       Impact factor: 4.307

Review 3.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

4.  Sequential activation of JAKs, STATs and xanthine dehydrogenase/oxidase by hypoxia in lung microvascular endothelial cells.

Authors:  Guansong Wang; Pin Qian; Fannie R Jackson; Guisheng Qian; Guangyu Wu
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

Review 5.  Redox regulation of Janus kinase: The elephant in the room.

Authors:  Roy J Duhé
Journal:  JAKSTAT       Date:  2013-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.